Amazon Biotech Inc. records show no insider trading activity within the last three months. The most recent transactions occurred in May 2005, when Chief Technology Officer Chaim Justman executed multiple sales of company shares. Historical data indicates previous divestment patterns by executives, including a significant sale by the Secretary/Treasurer during February 2004.